1. Home
  2. TNGX vs WYHG Comparison

TNGX vs WYHG Comparison

Compare TNGX & WYHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • WYHG
  • Stock Information
  • Founded
  • TNGX 2014
  • WYHG 1915
  • Country
  • TNGX United States
  • WYHG China
  • Employees
  • TNGX N/A
  • WYHG N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • WYHG
  • Sector
  • TNGX Health Care
  • WYHG
  • Exchange
  • TNGX Nasdaq
  • WYHG NYSE
  • Market Cap
  • TNGX 351.2M
  • WYHG 362.4M
  • IPO Year
  • TNGX N/A
  • WYHG 2024
  • Fundamental
  • Price
  • TNGX $5.16
  • WYHG $1.30
  • Analyst Decision
  • TNGX Strong Buy
  • WYHG
  • Analyst Count
  • TNGX 6
  • WYHG 0
  • Target Price
  • TNGX $12.20
  • WYHG N/A
  • AVG Volume (30 Days)
  • TNGX 3.9M
  • WYHG 142.2K
  • Earning Date
  • TNGX 08-06-2025
  • WYHG 08-15-2025
  • Dividend Yield
  • TNGX N/A
  • WYHG N/A
  • EPS Growth
  • TNGX N/A
  • WYHG N/A
  • EPS
  • TNGX N/A
  • WYHG 0.20
  • Revenue
  • TNGX $40,990,000.00
  • WYHG $147,996,867.00
  • Revenue This Year
  • TNGX N/A
  • WYHG N/A
  • Revenue Next Year
  • TNGX N/A
  • WYHG N/A
  • P/E Ratio
  • TNGX N/A
  • WYHG $4.68
  • Revenue Growth
  • TNGX 10.09
  • WYHG 19.02
  • 52 Week Low
  • TNGX $1.03
  • WYHG $1.12
  • 52 Week High
  • TNGX $12.02
  • WYHG $12.00
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 79.99
  • WYHG N/A
  • Support Level
  • TNGX $4.40
  • WYHG N/A
  • Resistance Level
  • TNGX $5.37
  • WYHG N/A
  • Average True Range (ATR)
  • TNGX 0.65
  • WYHG 0.00
  • MACD
  • TNGX 0.10
  • WYHG 0.00
  • Stochastic Oscillator
  • TNGX 93.68
  • WYHG 0.00

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About WYHG WING YIP FOOD HOLDINGS GROUP LTD SPON ADS EACH REP 1 ORD

Wing Yip Food Holdings Group Ltd is a meat producer. The company is mainly engaged in offering ready to eat and packaged meat dishes. Its product offerings include supreme crispy sausage, fully thin sausage, Chinese sausage, Dongguan Erba sausage, yellow scorpion sausage, alcohol sausage, and meat chop.

Share on Social Networks: